| The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer’s disease A Verma, DK Waiker, B Bhardwaj, P Saraf, SK Shrivastava Bioorganic Chemistry 119, 105562, 2022 | 46 | 2022 |
| Design, synthesis, and evaluation of some novel biphenyl imidazole derivatives for the treatment of Alzheimer's disease SP Ramrao, A Verma, DK Waiker, PN Tripathi, SK Shrivastava Journal of Molecular Structure 1246, 131152, 2021 | 20 | 2021 |
| Design, Synthesis, and Biological Evaluation of Piperazine and N-Benzylpiperidine Hybrids of 5-Phenyl-1,3,4-oxadiazol-2-thiol as Potential Multitargeted Ligands … DK Waiker, A Verma, Akhilesh, N Singh, A Roy, H Dilnashin, V Tiwari, ... ACS Chemical Neuroscience 14 (11), 2217-2242, 2023 | 19 | 2023 |
| Design and development of benzyl piperazine linked 5-phenyl-1, 2, 4-triazole-3-thione conjugates as potential agents to combat Alzheimer’s disease PVR Kiran, DK Waiker, A Verma, P Saraf, B Bhardwaj, H Kumar, A Singh, ... Bioorganic Chemistry 139, 106749, 2023 | 17 | 2023 |
| Morpholine substituted quinazoline derivatives as anticancer agents against MCF-7, A549 and SHSY-5Y cancer cell lines and mechanistic studies AR Dwivedi, V Kumar, V Prashar, A Verma, N Kumar, J Parkash, V Kumar RSC Medicinal Chemistry 13 (5), 599-609, 2022 | 16 | 2022 |
| Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and β-Secretase for treatment of Alzheimer's disease SK Shrivastava, AA Nivrutti, B Bhardwaj, DK Waiker, A Verma, PN Tripathi, ... Journal of Molecular Structure 1262, 132979, 2022 | 13 | 2022 |
| Development and Evaluation of Some Molecular Hybrids of N-(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1,3,4-oxadiazol-2-yl)thio) as Multifunctional Agents to Combat … DK Waiker, A Verma, P Saraf, G TA, S Krishnamurthy, RN Chaurasia, ... ACS omega 8 (10), 9394-9414, 2023 | 11 | 2023 |
| Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer’s Disease Therapy A Verma, DK Waiker, N Singh, A Roy, N Singh, P Saraf, B Bhardwaj, ... ACS Chemical Neuroscience 15 (4), 745-771, 2024 | 8 | 2024 |
| Structure-Guided Design, Synthesis, and Biological Evaluation of Peripheral Anionic Site Selective and Brain Permeable Novel Oxadiazole-Piperazine Conjugates against Alzheimer … A Singh, A Verma, B Bhardwaj, P Saraf, H Kumar, N Jain, DK Waiker, ... ACS omega 9 (16), 18169-18182, 2024 | 3 | 2024 |
| Synthesis, characterization, and biological evaluation of some novel ϒ-aminobutyric acid aminotransferase (GABA-AT) inhibitors SK Shrivastava, O Sinha, M Kumar, DK Waiker, A Verma, PN Tripathi, ... Medicinal Chemistry Research 31 (9), 1594-1610, 2022 | 3 | 2022 |
| Design, synthesis, and biological evaluation of some 2-(3-oxo-5, 6-diphenyl-1, 2, 4-triazin-2 (3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy DK Waiker, A Verma, TA Gajendra, A Roy, P Kumar, SK Trigun, ... European Journal of Medicinal Chemistry 271, 116409, 2024 | 2 | 2024 |
| Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment A Verma, DK Waiker, N Singh, A Singh, P Saraf, B Bhardwaj, P Kumar, ... European Journal of Medicinal Chemistry 271, 116450, 2024 | 2 | 2024 |
| Design, synthesis, and evaluation of benzhydrylpiperazine-based novel dual COX-2/5-LOX inhibitors with anti-inflammatory and anti-cancer activity P Saraf, B Bhardwaj, A Verma, MA Siddiqui, H Verma, P Kumar, ... RSC Medicinal Chemistry, 2025 | 1 | 2025 |
| An overview of important natural products and phytomedicines used for management of melasma D Dubey, L Chaudhari, A Biharee, A Verma, P Kumar, M Shrivastava World Journal of Pharmaceutical Research 10 (4), 744-55, 2021 | 1 | 2021 |
Sushant K ShrivastavaProfessor of Pharmaceutical ChemistryVerified email at itbhu.ac.in